FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056220331> ?p ?o ?g. }

• W2056220331 endingPage "296" @default.
• W2056220331 startingPage "290" @default.
• W2056220331 abstract "Previous studies from this laboratory have shown that the novel anti-inflammatory agent, lisofylline (LSF), improves oral glucose tolerance in streptozotocin (STZ) diabetic rats. Subsequent studies suggested that the improved glucose tolerance could be the result of enhanced beta-cell functioning. The possibility that LSF enhancement of insulin release in these animals is the result of direct effects of this agent on a residual population of functionally normal beta cells was further evaluated in these studies. In vivo studies: 6- to 8-week-old male rats were administered STZ (35 mg/kg body weight) intravenously. After 10 days, LSF administration (25 mg/kg body weight, twice daily) was initiated in the treated group (n = 11) for comparison with the vehicle-injected controls (n = 10). Body weight, food intake, and serum glucose and insulin levels were monitored weekly. Glucose and insulin responses to an oral glucose bolus were measured at 4 to 5 weeks as an index of LSF effects on impaired glucose tolerance. Glucose areas under curve (AUC) during the 2-hour tolerance tests in the LSF-treated rats (n = 11) were 23,390 +/- 253 versus 29,390 +/- 1,006 mg/dL x min (P <.0001) in the vehicle-injected rats (n = 10). Improved glucose tolerance was associated with increases in blood insulin levels in the LSF-treated rats, AUC (+LSF) = 6,564 +/- 66 versus 5,127 +/- 633 microU/mL x min in the vehicle-injected STZ-rats (not significant [NS]). These observations suggested that the improved glucose tolerance is the result of direct effects of LSF on glucose-induced release of insulin.the validity of this hypothesis was subsequently tested using isolated perfused pancreas preparations from normal rats. In this series of experiments, 12-week-old animals were used, and pancreases were perfused in situ using single-pass technique. Three levels of LSF were directly infused into individual pancreas preparations and included 20 (n = 5), 40 (n = 4), and 60 (n = 4) micromol/L. First (minutes 3 to 10) and second (minutes 13 to 35) phase glucose-stimulated (300 mg/dL) insulin response areas (AUC) for the 2 phases measured in the LSF-infused pancreases were compared with AUC in vehicle-infused pancreases (n = 4). At LSF concentrations of 20 and 40 micromol/L, total insulin released during the first phase of glucose stimulation was more than twice that of the controls (3,919 +/- 739 and 3,643 +/- 630 microU, respectively v 1,481 +/- 269 microU, P <.03). A total of 60 micromol/L LSF did not significantly enhance first phase glucose-induced insulin secretion. Second phase comparisons of total insulin released in the LSF-infused versus the controls showed differences of comparable magnitude (about 2-fold) with statistical significance (P <.03) observed at all 3 levels of LSF. These findings demonstrate that LSF enhances glucose-stimulated insulin release in vitro. Enhanced beta-cell functioning by LSF likely represents an important factor underlying improved glucose tolerance in vivo. In addition, the in vitro observations in normal rat pancreas indicate that the LSF effect is not limited to beta-cell dysfunction per se. These results support the conclusion that agents, such as LSF, may have therapeutic benefits in type 2 diabetes." @default.
• W2056220331 created "2016-06-24" @default.
• W2056220331 creator A5041082376 @default.
• W2056220331 creator A5086802524 @default.
• W2056220331 date "2004-03-01" @default.
• W2056220331 modified "2023-09-30" @default.
• W2056220331 title "Lisofylline, a novel anti-inflammatory agent, enhances glucose-stimulated insulin secretion in vivo and in vitro: studies in prediabetic and normal rats" @default.
• W2056220331 cites W1967616869 @default.
• W2056220331 cites W1983408914 @default.
• W2056220331 cites W1989290512 @default.
• W2056220331 cites W2013300862 @default.
• W2056220331 cites W2021925516 @default.
• W2056220331 cites W2040761158 @default.
• W2056220331 cites W2042203830 @default.
• W2056220331 cites W2043113739 @default.
• W2056220331 cites W2045838525 @default.
• W2056220331 cites W2054156175 @default.
• W2056220331 cites W2078073869 @default.
• W2056220331 cites W2086144613 @default.
• W2056220331 cites W2117647378 @default.
• W2056220331 cites W2120758187 @default.
• W2056220331 cites W2152530907 @default.
• W2056220331 cites W2316425445 @default.
• W2056220331 cites W2325141384 @default.
• W2056220331 cites W40321310 @default.
• W2056220331 cites W4234744307 @default.
• W2056220331 cites W4235235032 @default.
• W2056220331 cites W4241287361 @default.
• W2056220331 cites W4242018812 @default.
• W2056220331 cites W4252630246 @default.
• W2056220331 cites W4253131209 @default.
• W2056220331 doi "https://doi.org/10.1016/j.metabol.2003.10.008" @default.
• W2056220331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15015139" @default.
• W2056220331 hasPublicationYear "2004" @default.
• W2056220331 type Work @default.
• W2056220331 sameAs 2056220331 @default.
• W2056220331 citedByCount "25" @default.
• W2056220331 countsByYear W20562203312014 @default.
• W2056220331 countsByYear W20562203312015 @default.
• W2056220331 countsByYear W20562203312017 @default.
• W2056220331 countsByYear W20562203312018 @default.
• W2056220331 countsByYear W20562203312019 @default.
• W2056220331 countsByYear W20562203312021 @default.
• W2056220331 countsByYear W20562203312022 @default.
• W2056220331 crossrefType "journal-article" @default.
• W2056220331 hasAuthorship W2056220331A5041082376 @default.
• W2056220331 hasAuthorship W2056220331A5086802524 @default.
• W2056220331 hasConcept C126322002 @default.
• W2056220331 hasConcept C134018914 @default.
• W2056220331 hasConcept C150903083 @default.
• W2056220331 hasConcept C185592680 @default.
• W2056220331 hasConcept C207001950 @default.
• W2056220331 hasConcept C2777391703 @default.
• W2056220331 hasConcept C2779280383 @default.
• W2056220331 hasConcept C2779306644 @default.
• W2056220331 hasConcept C2780609358 @default.
• W2056220331 hasConcept C2780833929 @default.
• W2056220331 hasConcept C2908647359 @default.
• W2056220331 hasConcept C43376680 @default.
• W2056220331 hasConcept C555293320 @default.
• W2056220331 hasConcept C71924100 @default.
• W2056220331 hasConcept C76318530 @default.
• W2056220331 hasConcept C86803240 @default.
• W2056220331 hasConcept C99454951 @default.
• W2056220331 hasConceptScore W2056220331C126322002 @default.
• W2056220331 hasConceptScore W2056220331C134018914 @default.
• W2056220331 hasConceptScore W2056220331C150903083 @default.
• W2056220331 hasConceptScore W2056220331C185592680 @default.
• W2056220331 hasConceptScore W2056220331C207001950 @default.
• W2056220331 hasConceptScore W2056220331C2777391703 @default.
• W2056220331 hasConceptScore W2056220331C2779280383 @default.
• W2056220331 hasConceptScore W2056220331C2779306644 @default.
• W2056220331 hasConceptScore W2056220331C2780609358 @default.
• W2056220331 hasConceptScore W2056220331C2780833929 @default.
• W2056220331 hasConceptScore W2056220331C2908647359 @default.
• W2056220331 hasConceptScore W2056220331C43376680 @default.
• W2056220331 hasConceptScore W2056220331C555293320 @default.
• W2056220331 hasConceptScore W2056220331C71924100 @default.
• W2056220331 hasConceptScore W2056220331C76318530 @default.
• W2056220331 hasConceptScore W2056220331C86803240 @default.
• W2056220331 hasConceptScore W2056220331C99454951 @default.
• W2056220331 hasIssue "3" @default.
• W2056220331 hasLocation W20562203311 @default.
• W2056220331 hasLocation W20562203312 @default.
• W2056220331 hasOpenAccess W2056220331 @default.
• W2056220331 hasPrimaryLocation W20562203311 @default.
• W2056220331 hasRelatedWork W138803513 @default.
• W2056220331 hasRelatedWork W1986132654 @default.
• W2056220331 hasRelatedWork W1992838000 @default.
• W2056220331 hasRelatedWork W2004880720 @default.
• W2056220331 hasRelatedWork W2010140898 @default.
• W2056220331 hasRelatedWork W2026316039 @default.
• W2056220331 hasRelatedWork W2028627743 @default.
• W2056220331 hasRelatedWork W2082140668 @default.
• W2056220331 hasRelatedWork W2588049939 @default.
• W2056220331 hasRelatedWork W4234612679 @default.
• W2056220331 hasVolume "53" @default.
• W2056220331 isParatext "false" @default.

• next